In summary, five diagnostic biomarkers (HSPA5, HSP90B1, DNAJC3, PDIA6, and HERPUD1) were identified in EMs, providing new perspectives for the diagnosis, mechanism, investigation, and management of EMs. This evidence concerns the gene HSP90B1 and eosinophilia-myalgia syndrome.